For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently delay the need for systemic therapy for at least 1 year.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/sbrt-delays-systemic-therapy-oligometastatic-cancers-2025a10010rz?src=rss
Author :
Publish date : 2025-12-31 11:21:00
Copyright for syndicated content belongs to the linked Source.